NIH RPPR and Final RPPR progress reports must be reviewed and approved by the Office of Sponsored Programs (OSP) prior to submission to NIH. The progress report must be submitted electronically via ...

All NIH grant applications must pass all validations in NIH ASSIST before submitting to OSP. Your submission of the Complete Final and Error-Free Proposal to OSP must include a screenshot/image ...

Notice NOT-OD-23-161 updates the NIH application instructions for submitting requests for Data Management and Sharing costs in a single line item. As outlined in the Final NIH Policy on Data ...

NIH is hosting a free webinar regarding 2024 NIH Grants Policy Updates on Jan. 31 from 1 to 2:30 p.m. Register online for the webinar. Upon completion of this webinar, participants will be able to: ...

A scientific integrity plan recently proposed by the US National Institutes of Health (NIH) is “fundamentally flawed,” according to the Public Employees for Environmental Responsibility (PEER ...

On May 22, 2024, the National Institutes of Health Office of Science Policy issued a Request for Information on its Draft NIH Intramural Research Program Policy: Promoting Equity Through Access ...

The rapid turnaround from NIH-OSP in granting the request is a demonstration of the close collaboration between researchers, safety professionals and regulatory entities at Texas Biomed." ...

The Vice Provost for Research and the Office of Sponsored Programs are tracking information regarding federal funding in light of recent executive orders to determine their impact on sponsored ...

No articles found. NIH Office of Science Policy (OSP) did not contribute to any primary research papers from Nature Index journals in the current 12 month window.

Texas Biomed has now received approval from the National Institutes of Health Office of Science Policy (NIH-OSP) to work with the attenuated virus in its biosafety level (BSL-2) laboratories.

The Office of Research and Economic Development will host the virtual seminar NIH Program Officer, featuring Lyric Jorgenson, NIH acting director of the Office of Science Policy, from 12:30-2 p.m. Jan ...

Texas Biomed Professor Luis Martinez-Sobrido and his lab have received approval from NIH-OSP to work with a weakened version of SARS-CoV-2 in BSL-2 settings.